Tom Beauvironnet

Investment Manager

Catherine Boule

Managing Partner

Luca Brilliet

Investment Manager

Emmanuel Daugeras

Investment Director

Olivier Dubuisson

Managing Partner

Baudouin Hue

Partner

Benjamin Zerbib

Investment Director

133 past transactions

Exotrail

Series B in 2023
Exotrail develops electric propulsion solutions for small satellites. Their safe and efficient Hall Effect Thrusters are helping build agile constellations to revolutionize telecommunication, earth observation, space, and science. David Henri, Jean-Luc Maria, Paul Lascombes, and Nicolas Heitz co-founded the company in Palaiseau, Ile-de-France in 2015.

Ludocare

Seed Round in 2022
Ludocare is to create ways to provide assistance to patients and their families to improve their abilities, autonomy, and quality of life.

Vestack

Series A in 2022
Vestack is a PropTech company that manufactures and designs low-carbon buildings, pre-assembled on-site, and made of bio-sourced materials. Vestack's modular construction system enables it to address a wide range of uses, from residential to public buildings, in a variety of price ranges, and to accommodate a variety of architectural shapes and land plot constraints. Vestack works as a general contractor or construction company for real estate developers.

Leanspace

Seed Round in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

Kranus Health

Series A in 2022
Kranus Health is the leading global provider of virtual care in Urology. The company focuses on developing clinically validated therapies for a wide range of indications from Andrology to Uro-Oncology.

Implicity

Series A in 2022
Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of connected cardiac electronic implants. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of an artificial intelligence module and determines the criticality of each alert taking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform.

Humanlinker

Seed Round in 2022
Shaping the future of revenue generation. Humanlinker is a cutting-edge AI guided technology for revenue generation teams

Sitowie

Seed Round in 2022
Sitowie develops SaaS technology and tools to understand the degradation of buildings. Sitowie assists real estate decision-makers in the public and private sectors with sustainable building management in order to increase profitability, reduce carbon emissions, reduce energy consumption, and improve energy resilience. They offer a practical solution for firms managing a real estate portfolio, regardless of their level of data maturity.

i-Lunch

Series A in 2021
i-Lunch offers corporate catering services. I-Lunch provides businesses with adaptable, high-demand, and customized solutions. I-online Lunch's ordering platform offers useful and delectable recipes that are prepared in returnable glass containers and developed jointly by the company's nutritionists and chefs.

moveUP

Seed Round in 2021
moveUP develops and commercialise digital therapeutics solutions. Its closed loop system enables high compliance, better outcome and satisfaction. It uses continuously collected data to directly personalise the treatment of the patient. Its first therapy treats orthopaedic patients undergoing a joint surgery. It has CE medical device & ISO 13485 certification.

Vestack

Series A in 2021
Vestack is a PropTech company that manufactures and designs low-carbon buildings, pre-assembled on-site, and made of bio-sourced materials. Vestack's modular construction system enables it to address a wide range of uses, from residential to public buildings, in a variety of price ranges, and to accommodate a variety of architectural shapes and land plot constraints. Vestack works as a general contractor or construction company for real estate developers.

Exotrail

Series A in 2020
Exotrail develops electric propulsion solutions for small satellites. Their safe and efficient Hall Effect Thrusters are helping build agile constellations to revolutionize telecommunication, earth observation, space, and science. David Henri, Jean-Luc Maria, Paul Lascombes, and Nicolas Heitz co-founded the company in Palaiseau, Ile-de-France in 2015.

Eyevensys

Series B in 2020
Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasive procedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability. They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.

Tallano

Series A in 2019
Tallano technologie is a pioneer in the field of particle emission reduction systems for vehicle braking.

UPFACTOR

Seed Round in 2019
UPFACTOR is a Independent advisory body, specialist in large-scale detection of aerial land potential. Transversal expertise. (architecture, engineering, law).

TISSIUM

Series B in 2019
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues, and deliver on-demand wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC, and CapDecisif Management.

Incepto Medical

Seed Round in 2019
Healthcare professionals are now overwhelmed by the volume of patients and images. They need new tools. As safeguards of our Healthcare system, they need to be empowered and to participate in the AI production process. This is our mission through our co-creation projects.

cozycozy.com

Venture Round in 2019
Cozycozy is a search engine that allows travelers to compare the full range of available accommodation options, ensuring that they find the place that best meets their needs and always at the best price. It allows users to search for all available accommodation options in one place, including hotels, apartments, houses, youth hostels, lodges, boats, tree houses, cottages, cabins, and more.

Algaia

Acquisition in 2019
ALGAIA is a company developing, producing and commercializing Natural Extracts, mostly made out of seaweed. ALGAIA offers a unique range of Natural and Sustainable products & solutions to the Agro-Nutrition, Personal Care and Pharmaceutical industries. Following the acquisition of Alganact SA, ALGAIA is also opening a Service Division for customers and partners willing to better understand the potential of their seaweed biomass or characterize their extracts.

Implicity

Seed Round in 2019
Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of connected cardiac electronic implants. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of an artificial intelligence module and determines the criticality of each alert taking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform.

Misakey

Seed Round in 2019
Misakey is a developer of personal data protection platform designed to manage digital life.The company's platform gives access to all the sites where personal data is present, recover the data from those sites, request for update, deletion, limitation and freezing of data, helping citizens claim back control over their personal data.

Admo.tv

Series B in 2019
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.

Acticor Biotech

Series B in 2018
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains. Acticor Biotech was founded in November 2013 and is headquartered in Paris, France.

Acticor Biotech

Series B in 2018
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains. Acticor Biotech was founded in November 2013 and is headquartered in Paris, France.

Wisebatt

Seed Round in 2018
Wisebatt is a unique simulation tool for electronics engineers developing IoT devices. They can build virtual prototypes and collaborate to make the optimal choice between cost, battery life and performance, very early in the design cycle. Within minutes, hardware engineers access complex modeling results that would usually take weeks. Their technology leverages more than 15 years of academic research.

Wisebatt

Seed Round in 2018
Wisebatt is a unique simulation tool for electronics engineers developing IoT devices. They can build virtual prototypes and collaborate to make the optimal choice between cost, battery life and performance, very early in the design cycle. Within minutes, hardware engineers access complex modeling results that would usually take weeks. Their technology leverages more than 15 years of academic research.

Tricares

Series B in 2018
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Serious Factory

Series A in 2018
Serious Factory is a publisher of innovative learning solutions for training purposes. Thanks to its expertise in instructional engineering and gamification, Serious Factory can help make your entire training programme genuinely effective: from acquiring knowledge (digital learning modules, Serious Games, blended learning and much more) and developing and strengthening skills (practical work, behavioural simulator, etc.) to updating content and monitoring skills from day to day.

Appscho

Seed Round in 2018
AppScho is an EdTech player in Higher Education, helping students connect and engage with campus life while helping institutions gain measurable insights.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.

Acticor Biotech

Series A in 2018
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains. Acticor Biotech was founded in November 2013 and is headquartered in Paris, France.

Precogs

Venture Round in 2017
Precogs provides EMS-ODM-OEM businesses the best available prices for electronic components. Sourced in real-time.

PayinTech

Venture Round in 2017
In 2010, Bertrand Sylvestre-Boncheval and Jean-Rémi Kouchakji created a payment solution which relies on wristbands and handmade payment terminals to manage payments at HEC’s student bar. The system was then improved to scale up from tens to thousands of consumers. In 2012, they equipped the Hadra Trance Festival, the first 100% cashless festival in Europe, managing cashless payments of 14, 000 festival-goers at the festival’s bars and food stands. Two fundraisings of 1.1 million of euros in 2015 and of 4.5 million of euros in 2017 allowed the company to invest substantially in R&D and products and to diversify itself on all private payment markets. The main investor is La Caisse des Dépôts et Consignations (equivalent to the French sovereign fund). Nowadays, PayinTech is a worldwide fintech leader in cashless systems. The added value has always been the same: simplify transactional systems while allowing corporate customers to increase their on-site revenues, optimise management costs and to improve their users’ experience. Since 2015, PayinTech equips resorts, amusement parks, stadiums, events, local authorities, life bases, companies and NGOs in 16 countries from Europe, Africa, the Middle-East, Latin America and South-East Asia.

Acticor Biotech

Venture Round in 2017
Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors. However, only one treatment is presently recommended by health authorities and is it estimated that only 15% of ischemic stroke patients are treated with it, with less than 40% efficacy. So while this treatment is very useful for ischemic stroke, a major need for a new treatment capable of effectively treating a majority of ischemic stroke patients remains. Acticor Biotech was founded in November 2013 and is headquartered in Paris, France.

Ugloo

Venture Round in 2017
Ugloo, offers an indestructible data storage solution. This secondary storage solution allows you to upgrade the available space in the infrastructure as a virtual rack. Since Ugloo reuses the available space in the infrastructure, the company does not need additional investments and retains 100% governance over its data.

Nexdot

Venture Round in 2016
Nexdot develops the synthesis, the production, and the applications of a new generation of semiconductor nanocrystals with controlled size and shape: Quantum Dots (QDs). We are the world leader for the development of nanoplatelets – 2D nanosheet Quantum Dots with upgraded properties.They are a spin-off company from a world-class academic lab at ESPCI (Paris, France) in nanomaterial research and we benefit from more than ten years of experience in fundamental and applied research on nanomaterials and their technological applications. After four years of intense internal R&D efforts, we have developed unique know-how for the production of colloidal Quantum Dots and Nanoplatelets, Our proprietary materials with controlled shape and composition are unique and bring new expectations for use in displays, lighting, energy storage, detectors, and bio-imaging. Nexdot gathers young, enthusiastic, top level scientists and a board of senior executives with very strong track records on company management and innovation leadership.

Restlet

Convertible Note in 2016
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Tricares

Seed Round in 2016
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Linkfluence

Series C in 2016
Linkfluence, a social media intelligence company, specializes in analyzing conversations on the social web to create business opportunities for brands. Linkfluence offers a unique and powerful solution to monitor, measure, understand, and engage efficiently on the social web. The Radarly Product Suite (SaaS) – quick and easy to set up, user-friendly, and multilingual – collects all the relevant social media conversations around brands and provides actionable insights applicable across the organization. Radarly offers a solution for reputation management and provides ways to engage with key influencers, evaluate community management actions, detect potential crises and identify best practices. Linkfluence helps companies implement and roll out the tool to address specific needs: daily/weekly/monthly reports, campaign performance analysis, community profiling, brand perception audit, weak signal detection, and trend research. More than 200 high-profile companies in Europe chose Linkfluence to boost their social strategy. Linkfluence is VC backed by Orkos Capital, Banexi Ventures Partners, and Sigma Gestion.

NAVYA

Series B in 2016
NAVYA is a leading French name in the autonomous vehicle market and in smart shared mobility solutions. With more than 200 employees in France (Paris and Lyon) and in the United States (Michigan), NAVYA develops, manufactures and commercializes autonomous, driverless, and electric vehicles that combine robotic, digital and driving technologies at the highest level. Since 2015, NAVYA has been the first to market and put into service autonomous mobility solutions, shuttles and cabs. NAVYA has a range of two autonomous vehicles: the AUTONOM®SHUTTLE, launched in September 2015, of which more than 100 have already been produced as of today and 89 sold in 17 countries as of June 30, 2018, notably in the United States, France, Germany, Switzerland, Japan and Australia, and the AUTONOM®CAB, unveiled in November 2017 and whose first road tests will start shortly.

Stootie

Series A in 2016
Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick! This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime. The keywords of Stootie are : marketplace, P2P business, local, mobile, realtime, platform. Stootie is currently available on iOS and Android.

Playtem

Venture Round in 2016
Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.

Stereolabs

Venture Round in 2016
Stereolabs builds technology that perceives and understand the world the way humans do. Stereolabs is the company behind Linq, the first mixed reality headset which lets you play games like never before in a world where the real and virtual merge seamlessly. The company also builds the ZED stereo camera, a camera coupled with powerful software that allows any object to perceive depth and motion just like humans do. The ZED has been adopted by thousands of developers worldwide and is increasingly used by major game makers to power mixed-reality capture of VR and AR games. For more information, please visit: www.linqmr.com and www.stereolabs.com

Comiteo

Venture Round in 2016
Comitéo, founded in 2008, designs and innovative services adapted to works councils. Comitéo supports a simple idea: to facilitate the mission of the elected by offering a web platform and mobile application, highly configurable for access to technology, culture, recreation, management and communication.

Nexdot

Venture Round in 2016
Nexdot develops the synthesis, the production, and the applications of a new generation of semiconductor nanocrystals with controlled size and shape: Quantum Dots (QDs). We are the world leader for the development of nanoplatelets – 2D nanosheet Quantum Dots with upgraded properties.They are a spin-off company from a world-class academic lab at ESPCI (Paris, France) in nanomaterial research and we benefit from more than ten years of experience in fundamental and applied research on nanomaterials and their technological applications. After four years of intense internal R&D efforts, we have developed unique know-how for the production of colloidal Quantum Dots and Nanoplatelets, Our proprietary materials with controlled shape and composition are unique and bring new expectations for use in displays, lighting, energy storage, detectors, and bio-imaging. Nexdot gathers young, enthusiastic, top level scientists and a board of senior executives with very strong track records on company management and innovation leadership.

Restlet

Convertible Note in 2016
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Sevenhugs

Seed Round in 2016
Sevenhugs is the maker of Smart Remote—the world’s smartest and easiest to use remote control for your TV & smart home.

Bnbsitter

Series A in 2016
Bnbsitter allows vacation rental hosts to book welcome services for their guests. Guests’ check-in/check-out and rental cleaning are booked in less than two minutes. Busy at work, away for vacations or unable to meet arriving guests, Bnbsitter helps hosts to greet and welcome their guests with a smile!

TISSIUM

Series A in 2016
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues, and deliver on-demand wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC, and CapDecisif Management.

Melusyn

Seed Round in 2016
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

NAVYA

Venture Round in 2016
NAVYA is a leading French name in the autonomous vehicle market and in smart shared mobility solutions. With more than 200 employees in France (Paris and Lyon) and in the United States (Michigan), NAVYA develops, manufactures and commercializes autonomous, driverless, and electric vehicles that combine robotic, digital and driving technologies at the highest level. Since 2015, NAVYA has been the first to market and put into service autonomous mobility solutions, shuttles and cabs. NAVYA has a range of two autonomous vehicles: the AUTONOM®SHUTTLE, launched in September 2015, of which more than 100 have already been produced as of today and 89 sold in 17 countries as of June 30, 2018, notably in the United States, France, Germany, Switzerland, Japan and Australia, and the AUTONOM®CAB, unveiled in November 2017 and whose first road tests will start shortly.

Restlet

Convertible Note in 2015
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

MOPeasy

Venture Round in 2015
MOPeasy, ecomobility operator, provides solutions for car sharing of electric vehicules and others, car pooling and access and reservations for charging stations, all in one platform. THE community solution adapted to companies, cities and collective habitats. MOPeasy turns charging stations into mobility stations, operates from 1 to 50 vehicules fleet for a Company. and from 1 station in Rural Communities up to 100 stations across a territory. Interoperable, MOPeasy's platform brings ecomobility solutions for Smart cities.

NAVYA

Seed Round in 2015
NAVYA is a leading French name in the autonomous vehicle market and in smart shared mobility solutions. With more than 200 employees in France (Paris and Lyon) and in the United States (Michigan), NAVYA develops, manufactures and commercializes autonomous, driverless, and electric vehicles that combine robotic, digital and driving technologies at the highest level. Since 2015, NAVYA has been the first to market and put into service autonomous mobility solutions, shuttles and cabs. NAVYA has a range of two autonomous vehicles: the AUTONOM®SHUTTLE, launched in September 2015, of which more than 100 have already been produced as of today and 89 sold in 17 countries as of June 30, 2018, notably in the United States, France, Germany, Switzerland, Japan and Australia, and the AUTONOM®CAB, unveiled in November 2017 and whose first road tests will start shortly.

Mitricares

Seed Round in 2015
MITRICARES aims to develop and market an implantable medical device for percutaneous treatment of tricuspid valves failed. The young company has already realized a first prototype successfully tested several times on the big animal. This new system would address a major public health problem, tricuspid insufficiency, which affects 4 million people in Europe and the USA, with a poor prognosis in the short term.

SetKeeper

Venture Round in 2015
SetKeeper is a developer of an application platform intended to coordinate the physical production process simply and safely. The company's platform provides document watermarking and distribution, script sides, electronic signature service for operational and technical management of audiovisual projects such as films, TV shows, broadcasts, clips, commercials, video games, and animation as well as revolutionize the production landscape with new and empowering technologies and contribute to the creation of amazing stories, enabling customers to keep track of and optimize their schedules

Aterovax

Seed Round in 2015
Aterovax is an in vitro diagnostic (IVD) company that develops innovative solutions to predict, diagnose and prevent cardiovascular disease through its Unique understanding of atherosclerosis.

Tricares

Seed Round in 2015
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

actvt

Seed Round in 2015
Actvt Inc. aims to break the barriers to social video through cutting edge video editing technology. We turn long videos into short-form content that's actually fun to watch and share. Product portfolio: * Activity: An assisted video editing and social networking app that lets users effortlessly select highlights from their footage and automatically generate short edits on-the-go. Available on iOS and Android. * Showdown.cc: An in-game replay plugin for game developers that allows players to create, share, and discover gameplay videos.

Prestodiag

Series A in 2015
Prestodiag develops, manufactures and sells innovative solutions for rapid detection of bacteria. Their analytical solutions are based on an innovative optics technology called Surface Plasmon Resonance imaging and allow detection and identification of pathogenic bacteria such as Salmonella, Listeria or E.coli. They provide users with a result in just a few hours instead of 1 to several days. Their market is primarily the food safety sector, and also on medical and environmental applications.

Eyevensys

Seed Round in 2015
Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasive procedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability. They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.

Melusyn

Seed Round in 2015
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

RED Technologies

Seed Round in 2015
RED Technologies is a provider of spectrum sharing technologies, focusing on dynamic spectrum access for private 5G networks. The company offers scalable cloud-based solutions, enabling operators to modernize communication infrastructures efficiently. RED is actively involved in regulatory developments and standardization efforts to support the growing demand for accessible 5G services.

Serious Factory

Seed Round in 2015
Serious Factory is a publisher of innovative learning solutions for training purposes. Thanks to its expertise in instructional engineering and gamification, Serious Factory can help make your entire training programme genuinely effective: from acquiring knowledge (digital learning modules, Serious Games, blended learning and much more) and developing and strengthening skills (practical work, behavioural simulator, etc.) to updating content and monitoring skills from day to day.

English Attack

Series A in 2015
English Attack is a Web 2.0, entertainment-driven English language learning Entertainment Learning was created to bring leverage the power of digital entertainment to transform the way people learn. Its flagship service, English Attack! (www.english-attack.com) creates true innovation in the $35 billion market for English language learning via a 100% entertainment-driven approach to helping learners increase and enhance their exposure to, and use of, the language. It achieves this via interactive lessons based on clips from blockbuster movies, hit TV series, and television news reports; chart-topping music videos; professionally produced casual games; visual dictionaries; and a global social network of learners of English. Entertainment Learning was founded by experienced digital entertainment executives Paul Maglione and Frederic Tibout, who launched English Attack! commercially in 2012 after the service had won or been a finalist in several French and European startup competitions including Plugg Brussels, The Next Web Amsterdam, and Seedcamp Paris.

VitamFero

Series C in 2015
Incorporated in late 2005, VitamFero SA is a privately held biotech company whose mission, founded on an innovative and patented technology (i.e. Toxo KO), is to create, develop, register and market novel anti-infectious vaccines, first against Apicomplexe parasites such as: - Toxoplasma gondii (toxoplasmosis agent) - Neospora caninum (neosporosis agent) - Cryptosporidium parvum (cryptosporidiosis agent). With headquarters in Evry (France) and laboratories in Tours (France), VitamFero is involved first in veterinary healthcare.

PayinTech

Seed Round in 2015
In 2010, Bertrand Sylvestre-Boncheval and Jean-Rémi Kouchakji created a payment solution which relies on wristbands and handmade payment terminals to manage payments at HEC’s student bar. The system was then improved to scale up from tens to thousands of consumers. In 2012, they equipped the Hadra Trance Festival, the first 100% cashless festival in Europe, managing cashless payments of 14, 000 festival-goers at the festival’s bars and food stands. Two fundraisings of 1.1 million of euros in 2015 and of 4.5 million of euros in 2017 allowed the company to invest substantially in R&D and products and to diversify itself on all private payment markets. The main investor is La Caisse des Dépôts et Consignations (equivalent to the French sovereign fund). Nowadays, PayinTech is a worldwide fintech leader in cashless systems. The added value has always been the same: simplify transactional systems while allowing corporate customers to increase their on-site revenues, optimise management costs and to improve their users’ experience. Since 2015, PayinTech equips resorts, amusement parks, stadiums, events, local authorities, life bases, companies and NGOs in 16 countries from Europe, Africa, the Middle-East, Latin America and South-East Asia.

Stootie

Seed Round in 2015
Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick! This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime. The keywords of Stootie are : marketplace, P2P business, local, mobile, realtime, platform. Stootie is currently available on iOS and Android.

Sevenhugs

Seed Round in 2015
Sevenhugs is the maker of Smart Remote—the world’s smartest and easiest to use remote control for your TV & smart home.

Sevenhugs

Acquisition in 2015
Sevenhugs is the maker of Smart Remote—the world’s smartest and easiest to use remote control for your TV & smart home.

Open Ocean

Seed Round in 2015
Open Ocean is an innovative company based in Brest and Paris, which conceives since 2011 online decision-making solutions for industrial marine activities. Their highly qualified team of oceanographers, trained in the best research oceanographic institutes of the world (UPMC, IFREMER, University of Washington) is specialized in high resolution modelling, statistical analysis and data mining.

Pherecydes Pharma

Series A in 2014
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.

Restlet

Convertible Note in 2014
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Web Geo Services

Seed Round in 2014
Web Geo Services specializes in location SaaS technology for Retail, Ecommerce, Travel & Hospitality, Banking & Insurance, Automotive and Mobility. Web Geo Services helps companies to leverage their Google Maps as a powerful tool to engage with their customers and drive conversion. Web Geo Services brings its expertise in the area of online mapping and geolocation data to support prestigious international brands in the fast deployment of digital systems that accelerate online checkout and online customer journeys. With more than 400 Large companies, Web Geo Services has been a Strategic Partner of Google Cloud since 2009. WGS is the European Google Maps Leading Partner in Europe with offices in United Kingdom, Netherlands, France, Italy and Spain. Our experience and tireless innovation has led us to build leading applications that can give businesses a competitive advantage. Web Geo Services has built Woosmap, the Google awarded Platform that helps developers to integrate powerful Location Intelligence features in their Mobile Apps and Websites.

Playtem

Venture Round in 2014
Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.

Precogs

Seed Round in 2014
Precogs provides EMS-ODM-OEM businesses the best available prices for electronic components. Sourced in real-time.

Rool'in

Seed Round in 2014
Rool'in offers innovative, practical and ecological solutions in the field of bicycle mobility.

Neelogy

Seed Round in 2013
Neelogy develops and markets non-remanence magnetic sensors (thus very precise and non-intrusive) for the measurement of alternating and continuous electrical currents. The company's mission: to meet new needs related to energy metering, AC / DC energy conversion, electrical energy storage, real-time fault detection and diagnostics.

Axess Vision Technology

Series B in 2013
Axess Vision Technology S.A. is a French company specializing in the design and production of disposable sterile endoscopes for various medical applications, including bronchoscopy and urology. Founded in 2006 and headquartered in Saint-Pierre-des-Corps, the firm has dedicated significant resources to research and development, culminating in the commercialization of its first single-use endoscope in 2014. With a focus on patient safety and comfort, Axess Vision Technology aims to enhance the efficiency of medical practitioners while addressing emerging health challenges. The company has introduced several innovative products, backed by collaboration with medical experts and a commitment to sustainability and community engagement. Through its ongoing efforts, Axess Vision has secured multiple patents and continues to prioritize innovation in the evolving healthcare landscape.

TISSIUM

Series A in 2013
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues, and deliver on-demand wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC, and CapDecisif Management.

Aterovax

Seed Round in 2013
Aterovax is an in vitro diagnostic (IVD) company that develops innovative solutions to predict, diagnose and prevent cardiovascular disease through its Unique understanding of atherosclerosis.

Stereolabs

Seed Round in 2013
Stereolabs builds technology that perceives and understand the world the way humans do. Stereolabs is the company behind Linq, the first mixed reality headset which lets you play games like never before in a world where the real and virtual merge seamlessly. The company also builds the ZED stereo camera, a camera coupled with powerful software that allows any object to perceive depth and motion just like humans do. The ZED has been adopted by thousands of developers worldwide and is increasingly used by major game makers to power mixed-reality capture of VR and AR games. For more information, please visit: www.linqmr.com and www.stereolabs.com

Restlet

Seed Round in 2013
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

AlephD

Series A in 2013
AlephD provides real-time solutions to publishers selling inventory over RTB. Founded in 2012 by a former Criteo executive and two data scientists and serial entrepreneurs, AlephD provides real-time capabilities to online publishers. Its solutions instantly boost digital publishers RTB revenues (Real Time Bidding) by up to 30%. The company developed real-time algorithms able to predict auction performance right before each impression is served. On behalf of its clients, AlephD chooses the best selling strategy to attract the most relevant buyers at the best price. The algorithms are fine tuned over billions of auction logs stored on a big data infrastructure. They are then applied thousands of times per second for every single impression delivered by AlephD’s customers, offering instantaneous revenue boost. AlephD equips online publishers with the same level of technology as the most advanced advertisers or demand-side solutions. AlephD leverages all the publisher data to create a level playing field in the RTB market and unlocks new opportunities for buyers and sellers.

Fidzup

Seed Round in 2013
Fidzup provides web oriented tools to brick & mortar businesses. The company has created a unique instore analytics platform that allows retailers to retarget their customers with personalized ads on mobile. The company was incorporated in 2013 and is based in Paris, France.

Fidzup

Angel Round in 2013
Fidzup provides web oriented tools to brick & mortar businesses. The company has created a unique instore analytics platform that allows retailers to retarget their customers with personalized ads on mobile. The company was incorporated in 2013 and is based in Paris, France.

Nanoe

Seed Round in 2013
Nanoe is a manufacturer of products based on nanopowders specifically adapted to the market of technical ceramics.

e(ye)BRAIN

Series B in 2012
e(ye)BRAIN is a medical company that manufactures and distributes eye trackers for its clients. e(ye)BRAIN’s range of products include Eye Brain T1 and T2. The T1 enables its users to record eye movements. T2 uses algorithms to enable its users to record eye and head movements. The recorded movements will be analyzed by a software called MeyeEval. The company offers advisory, paradigm development, formation, and support services to its clients. e(ye)BRAIN was founded in 2008 by Serge Kinkingnehun and is based in France.

WeCook WeCare

Seed Round in 2012
WeCook WeCare offers a tailor-made slimming and quality of life program to reach the ideal weight and transform life. The platform that addresses the challenges of weight loss and recovery of quality of life for all.

Stryng

Seed Round in 2012
Stryng is a messaging app that helps businesses connect with their customers. They combine live chat, audio, video communication, live collaboration tools, and automatically classify messages by customers to keep track of customer communication in one place. They enable mobile to increase sales and deliver customers online.

Plasmabiotics

Seed Round in 2012
PlasmaBiotics is a young innovative company.The core focus of Plasmabiotics, addressed through its core products, the PlasmaTYPHOON, and the PlasmaBAG, is to increase the efficiency of hospitals and to minimize the risk of bacterial contamination.

Green Point SAS

Seed Round in 2012
GreenPoint specialises in regtech, namely in digital and mobile management of know your customer (KYC), digital processing of customers’ records and customer on-boarding.

Plasmabiotics

Acquisition in 2012
PlasmaBiotics is a young innovative company.The core focus of Plasmabiotics, addressed through its core products, the PlasmaTYPHOON, and the PlasmaBAG, is to increase the efficiency of hospitals and to minimize the risk of bacterial contamination.

VitamFero

Seed Round in 2011
Incorporated in late 2005, VitamFero SA is a privately held biotech company whose mission, founded on an innovative and patented technology (i.e. Toxo KO), is to create, develop, register and market novel anti-infectious vaccines, first against Apicomplexe parasites such as: - Toxoplasma gondii (toxoplasmosis agent) - Neospora caninum (neosporosis agent) - Cryptosporidium parvum (cryptosporidiosis agent). With headquarters in Evry (France) and laboratories in Tours (France), VitamFero is involved first in veterinary healthcare.

EVIAGENICS

Series A in 2011
EVIAGENICS is a biotechnology company generating new products and improved manufacturing processes for the chemical and pharmaceutical industry by applying its unique in vivo recombination technology. After the successful validation of the technology in several collaborations with industrial partners from red and white biotechnology EVIAGENICS will focus its activities on the development of a technology platform for the efficient recombination and expression of metabolic pathways in cells. These reprogrammed cells will be able to transform sugars from cheap renewable sources like feedstock into numerous new high value compounds.

Physikron

Seed Round in 2010
Physikron is a developer of mass spectrometry technologies used to improve the performance of tandem spectrometry. Its technologies offer proteomic analysis and dramatically improves the number of peptides and proteins identified during an LC/MS/MS acquisition that enable researchers to research in an enhanced way.

Edenwall Technologies

Seed Round in 2010
Edenwall is a security vendor of identity-based firewall connection filtering solutions.

Algaia

Seed Round in 2010
ALGAIA is a company developing, producing and commercializing Natural Extracts, mostly made out of seaweed. ALGAIA offers a unique range of Natural and Sustainable products & solutions to the Agro-Nutrition, Personal Care and Pharmaceutical industries. Following the acquisition of Alganact SA, ALGAIA is also opening a Service Division for customers and partners willing to better understand the potential of their seaweed biomass or characterize their extracts.

Nanobiotix

Series C in 2010
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.